Latest Advances in the Treatment of Early Onset Scoliosis

Faculty:

• Suken A Shah

  Nemours/Alfred I. duPont Hospital for Children, Wilmington, DE.

• Richard E McCarthy

  University of Arkansas for Medical Sciences, Little Rock, AR.

• Gregory Mundis

  San Diego Center for Spinal Disorders, San Diego, CA.

• John Smith

  University of Utah, Salt Lake City, UT.

Expiration: 12/22/2015

Location: Online

Requirements for successful completion: In order to receive credit, participants must view all audio-visual presentations and complete both the pre-test, post-test and evaluation form. Participants must score 100% on the activity post-test in order to receive credit. There are no pre-requisites for this activity. Course attendance verification forms are provided upon successful completion of the post-test and evaluation form. No partial credit will be given.

Target Audience: Physicians, residents and trainees, fellows, nurses, surgical techs, physical therapists, and other members of the allied health community whose scope of practice encompasses Orthopaedics.

Course Description: In this live webinar, expert Pediatric, Spine will present optimal operable techniques and treatment options to address Latest Advances in the Treatment of Early Onset Scoliosis. The webinar features time for interactive audience discussion and surgical case based scenarios.

Learning Objectives: Upon completion of this activity, participants should be better able to discuss:

1. Discuss evaluation and nonoperative management of early onset scoliosis
2. Discuss the use of growth-guided instrumentation for spinal deformity correction
3. Discuss the use of magnetically-controlled growing rods for spinal deformity
4. Discuss the use of rib-based distraction systems as a treatment of early onset scoliosis

Credits: This lecture qualifies for 2 CME credit hours.

Cost: $0.0

Accreditation Statement: This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the International Institute for Continuing Medical Education and VuMedi. The International Institute for Continuing Medical Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide medical education to physicians.

Designation Statement: The International Institute for Continuing Medical Education, Inc designates this live activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Disclosures: Faculty Disclosures/Conflict of Interest Policy\nIn accordance with ACCME requirements, The International Institute for Continuing Medical Education, Inc, has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced. The relationships were reviewed by The International Institute for Continuing Medical Education, Inc. and conflicts of interest were resolved prior to the activity.

Dr. Dr. Suken Shah discloses the following relevant financial relationships with a commercial interest:
AAOS: Board or committee member, Arthrex, Inc.: IP royalties, DePuy Synthes Spine: IP royalties; Paid consultant, DePuy Synthes Spine via Setting Scoliosis Straight Foundation: Research support, Ellipse Technologies: Paid consultant, Ethicon Endosurgery: Research support, Globus Medical: Stock or stock Options, K2M: Paid consultant, K2M via Setting Scoliosis Straight Foundation: Research support Orthopaediatrics: Unpaid consultant, Pediatric Orthopaedic Society of North America: Board or committee member, Scoliosis Research Society: Board or committee member, Setting Scoliosis Straight Foundation: Board or committee member, Stryker: Paid consultant

Dr. Richard McCarthy discloses the following relevant financial relationships with a commercial interest: Medtronic: IP royalties; Paid consultant; Paid presenter or speaker; Publishing royalties, financial or material.

Dr. Gregory Mundis discloses the following relevant financial relationships with a commercial interest: ISSGF: Research support, K2M: IP royalties; Paid consultant; Paid presenter or speaker, Medicrea: Paid consultant, Misonix: Paid consultant, Nuvasive: IP royalties; Paid consultant; Paid presenter or speaker; Research support.

Dr. John Smith discloses the following relevant financial relationships with a commercial interest: Consultant: Depuy-Synthes; Zimmer-Biomet; Spineguard; Globus medical; Ellipse (wife), Board of Directors: Children’s Spine Foundation, Royalties: VEPTR 2 device

Faculty Disclosures of Unlabeled Use: The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Dr. Dr. Suken Shah does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Richard McCarthy does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. Gregory Mundis does not intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Dr. John Smith does intend to discuss off-label uses of drugs, mechanical devices, biologics, or diagnostics approved by the FDA for use in the United States.

Commercial Support: No commercial support was received for this activity.

Software Requirements: VuMedi Webinars supports the following web browsers (with enabled JavaScript™): Internet Explorer® versions 6.0, 7.0, 8.0, Mozilla Firefox versions 1.0, 2.0, 3.0, and Safari for Mac. Certain educational activities may require additional software to view multimedia, presentation or printable versions of their content. That software may be: Adobe Acrobat®, Adobe® Flash Player, Microsoft® Office PowerPoint, and Microsoft® Office Word.These activities will be marked as such and will provide links to the required software.

Copyright: Any and/or all materials are for the exclusive use of the faculty and participants of the live activity. Any copying, duplicating or reproducing of any and/or all materials by electronic, mechanical or other means for any purpose other than this enduring activity is strictly prohibited without prior written consent of the author of those materials.

Policy on Privacy and Confidentiality: For more information regarding VuMedi's Policy on Privacy and Confidentiality, please visit http://www.vumedi.com/pages/privacy/

To Contact our Accredited Provider: 6438 US Hwy 11
Springville, AL 35146
Phone: (205) 467-0290
Fax: (205) 467-0195
email: iicmemail@gmail.com

For questions regarding this activity, please contact VuMedi: cme@vumedi.com